NCT01299805View on ClinicalTrials.gov

Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy
Interventions
DRUG

Vortioxetine

Encapsulated tablet

DRUG

Placebo

Vortioxetine placebo-matching capsules.

Trial Locations (1)

Unknown

Glendale

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY